← All stocks

Evommune, Inc.

EVMN Net buying

CIK 0002044725 #3118 in the set updated 17 Sep 2026

Bought (12 mo)

$70.16M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.28M

$673.75K on a plan · $1.61M straight out of an exercise

Sold at will

$0.00

0 of 9 sales

Net

+$67.88M

+$70.16M against sales at will

By person

13 insiders · 16 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LSP 7 Cooperative UA

Director

$25.00M (1)

—

+$25.00M

10,217,946

28.15%

$135.49M

+107.3%

Verduyn-van Weegen Felice Isabel

Director

$25.00M (1)

—

+$25.00M

5,288,313

14.57%

$70.12M

—

RA CAPITAL MANAGEMENT, L.P. entity

Director

$20.00M (2)

—

+$20.00M

2,710,293

7.47%

$35.94M

—

Pena Luis C.

President & CEO

—

$550.65K (2) scheduled

−$550.65K

630,458

1.74%

$8.36M

−4.3%

Drew Janice Suzann

Chief of Dev. Operations

—

$452.60K (1) scheduled

−$452.60K

67,794

0.1868%

$898.95K

−4.9%

Patel Jeegar Pravinkumar

Chief Scientific Officer

—

$412.94K (2) scheduled

−$412.94K

46,403

0.1279%

$615.30K

−13.9%

Carver Kyle

Chief Financial Officer

$13.26K (1)

$415.12K (1) scheduled

−$401.86K

60,335

0.1662%

$800.04K

−16.9%

Moss Gregory S.

Chief Business & Legal Officer

—

$324.71K (1) scheduled

−$324.71K

64,010

0.1764%

$848.77K

−14.0%

KIRSCH ARTHUR S

Director

$133.00K (1)

—

+$133.00K

10,000

0.0276%

$132.60K

—

Cohen David E

Director

—

$123.09K (2) scheduled

−$123.09K

17,609

0.0485%

$233.50K

0.0%

Hopfner Robert Lorne

Director

$17.35K (1)

—

+$17.35K

4,026

0.0111%

$53.38K

—

Pivotal bioVenture Partners Fund I, L.P. entity

Director

—

294,502

0.8115%

$3.91M

—

Bauer Eugene

Chief Medical Officer

—

270,818

0.7462%

$3.59M

+9.9%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 49

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 5

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 16,635,785

History held since 7 Nov 2025